These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 14577440
1. Indian experts favour IPV to eradicate polio. Sharma DC. Lancet; 2003 Oct 18; 362(9392):1292. PubMed ID: 14577440 [No Abstract] [Full Text] [Related]
2. Polio vaccines: WHO position paper – March, 2016. Wkly Epidemiol Rec; 2016 Mar 25; 91(12):145-68. PubMed ID: 27039410 [No Abstract] [Full Text] [Related]
3. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE). Falleiros-Arlant LH, Avila-Agüero ML, Brea del Castillo J, Mariño C. Rev Chilena Infectol; 2014 Oct 25; 31(5):590-603. PubMed ID: 25491459 [Abstract] [Full Text] [Related]
4. Innovation for polio eradication. Lancet Infect Dis; 2011 Oct 25; 11(10):721. PubMed ID: 21958571 [No Abstract] [Full Text] [Related]
5. Need for polio boosters after age two years. Rennels MB. Vaccine; 2009 Jan 07; 27(2):179-80. PubMed ID: 19007837 [No Abstract] [Full Text] [Related]
6. [Economic impact of introducing the injectable inactivated polio vaccine in Colombia]. Alvis N, De la Hoz F, Narváez J. Rev Panam Salud Publica; 2010 May 07; 27(5):352-9. PubMed ID: 20602069 [Abstract] [Full Text] [Related]
8. Polio vaccine: should New Zealand make the change? Baker C, Eberhart-Phillips J. N Z Med J; 1997 Sep 12; 110(1051):340-2. PubMed ID: 9323376 [No Abstract] [Full Text] [Related]
9. The cost-effectiveness of alternative polio immunization policies in South Africa. Griffiths UK, Botham L, Schoub BD. Vaccine; 2006 Jul 17; 24(29-30):5670-8. PubMed ID: 16766096 [Abstract] [Full Text] [Related]
10. A developing country perspective on vaccine-associated paralytic poliomyelitis. John TJ. Bull World Health Organ; 2004 Jan 17; 82(1):53-7; discussion 57-8. PubMed ID: 15106301 [Abstract] [Full Text] [Related]
11. Poliomyelitis in the United States: the final chapter? Modlin JF. JAMA; 2004 Oct 13; 292(14):1749-51. PubMed ID: 15479943 [No Abstract] [Full Text] [Related]
12. World wide experience with inactivated poliovirus vaccine. Bonnet MC, Dutta A. Vaccine; 2008 Sep 15; 26(39):4978-83. PubMed ID: 18680777 [Abstract] [Full Text] [Related]
13. Global eradication of poliomyelitis: is the end of the campaign in sight? Adams T. J Paediatr Child Health; 2010 Nov 15; 46(11):619-22. PubMed ID: 20163526 [Abstract] [Full Text] [Related]
14. Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis. Brown B. JAMA; 2010 Nov 15; 277(4):295. PubMed ID: 9002483 [No Abstract] [Full Text] [Related]
15. Polio endgame. The exit strategy. Roberts L. Science; 2004 Mar 26; 303(5666):1969-71. PubMed ID: 15044782 [No Abstract] [Full Text] [Related]
16. Change from oral poliovirus vaccine to inactivated poliovirus vaccine. Mele A, Jefferson T, Franco E, Salmaso S. Lancet; 2002 Oct 12; 360(9340):1178. PubMed ID: 12387987 [No Abstract] [Full Text] [Related]
17. WHO policy statement on polio vaccines. Wkly Epidemiol Rec; 1995 Dec 08; 70(49):346-7. PubMed ID: 8652353 [No Abstract] [Full Text] [Related]